-
Research Progress of Glucose Sensitive Insulin Intelligent Drug Delivery System
Time of Update: 2021-12-08
The pH-triggered insulin release system utilizes the gluconic acid produced when GOx oxidizes glucose, causing local pH to decrease, which in turn triggers changes in the carrier structure (dissociation, swelling, or collapse), and ultimately leads to drug release .
-
Kanghong Pharmaceutical Industry Vothiaxetine Hydrobromide Tablets Obtained Drug Registration Certificate
Time of Update: 2021-12-08
On November 10, Kanghong Pharmaceutical issued an announcement stating that the generic drug of Futhiaxetine hydrobromide tablets had recently been approved for marketing by the National Medical Products Administration .
-
Three quarterly reports exceed expectations, many pharmaceutical machinery companies are optimistic about institutions
Time of Update: 2021-12-08
In response to the three quarterly reports of Chutian, Tofflon and other listed pharmaceutical machinery companies exceeding expectations, a number of institutions issued "optimistic" research reports and maintained a "buy" rating .
-
Another city!
Time of Update: 2021-12-08
On November 9th, Astellas and Baiyang Pharmaceutical have joined hands, and the two parties have discussed the original research drugs of Astellas Betantil (Mirabegron sustained-release tablets), Weixikang (Sorinasine succinate tablets) and The promotion and operation of Halo (tamsulosin hydrochloride sustained-release capsules) in mainland China reached a deepening cooperation agreement, which will jointly explore the commercialization of urinary treatment drugs, improve drug availability, and better serve Chinese patients with urinary diseases .
-
Shanghai Songjiang Biopharmaceutical Industry Develops High-Quality Acceleration
Time of Update: 2021-12-08
As of June this year, there are nearly 3,000 companies related to the biomedical industry in Songjiang District, of which more than 1,800 were registered after the start of the construction of the Yangtze River Delta G60 Science and Technology Innovation Corridor in 2016, achieving a five-year increase of 1.
-
Under the continuous changes in the pharmaceutical market, pharmaceutical companies are accelerating the promotion of product reviews
Time of Update: 2021-12-08
According to relevant national policies, the types, quality and efficacy of drugs that have passed the consistency evaluation are equivalent to the original research products, and appropriate support will be given in terms of medical insurance payment and procurement by medical institutions .
-
Johnson & Johnson's blockbuster drug daratumumab gains new indications in China
Time of Update: 2021-12-08
Retrieved Nov 12, 2021, from https://® (Daratumumab) Shows Overall Survival Benefit and Continued Improvement in Progression-Free Survival in Patients with Newly Diagnosed Multiple Myeloma Who Are Ineligible for Transplant.
Retrieved Dec 9, 2019, from https:// darzalex-daratumumab-shows-overall-survival-benefit-and-continued-improvement-in-progression-free-survival-in-patients-with-newly-diagnosed-multiple-myeloma-who-are-ineligible-for-transplant
-
Two styles a day! Hengrui Medicine's anesthetics and eye drops were approved for listing in China today
Time of Update: 2021-12-08
According to the public information disclosed by Hengrui Medicine, it is speculated that the new indication for the drug approved this time may be general anesthesia or bronchoscopy sedation .
-
With favorable policies, Chinese medicine will play an important role in children's health care services
Time of Update: 2021-12-08
In addition, in May this year, the National Health Commission and the State Administration of Traditional Chinese Medicine also jointly issued the "Implementation Plan for Promoting Chinese Medicine in the Field of Maternal and Child Health (2021-2025)", which clearly stated that they would promote the development of Chinese medicine services in maternal and child health institutions.
-
Qinhao Pharmaceutical's SHP2 inhibitor was approved for clinical use
Time of Update: 2021-12-08
Article source: Pharmaceutical GuanlanOn November 10, the Center for Drug Evaluation (CDE) of the National Food and Drug Administration of China announced that the Class 1 new drug GH21 capsules declared by Qin Hao Medicine had obtained the implied license for clinical trials and planned to be developed for advanced solid tumors .
-
Gale announced that the Phase II clinical trial application of ASC22 (envolimab) for immune reconstitution/functional cure of human immunodeficiency virus type 1 (HIV-1) infected persons has been approved by the State Food and Drug Administration of China
Time of Update: 2021-12-08
(Hong Kong Stock Exchange code: 1672) today announced that its ASC22 (Envolimab) Phase II clinical trial application has been approved by China Approved by the National Medical Products Administration (NMPA) as a new indication for immune reconstitution/functional cure for people infected with human immunodeficiency virus type 1 (HIV-1) .
-
Deepen cooperation!
Time of Update: 2021-12-08
They continue to increase their investment in China, try their best to meet the unmet medical needs of Chinese patients, and at the same time accelerate the pace of their innovative products entering the market, ensure the demand for clinical treatment, and expand the availability of drugs .
-
Guangdong and Qinghai issued notices on drug quality sampling inspections for 7 varieties and 8 batches that did not meet the requirements
Time of Update: 2021-12-08
From November 10th to 11th, the drug regulatory bureaus of Guangdong and Qinghai provinces issued drug random inspection information notices. The notice showed that 47 batches of 39 varieties in Guan
-
A pharmacy lost 500,000 yuan due to illegal sales of prescription drugs
Time of Update: 2021-12-08
However, during the epidemic prevention period, pharmacies who sell prescription drugs in violation of regulations are often severely punished .
In response, the two pharmacies had their business licenses revoked for failing to sell drugs to confirmed cases in accordance with regulations .
-
Fierce Biotech's 2021 biopharmaceutical Waterloo event inventory
Time of Update: 2021-12-08
Last year the company’s hype about the 3-phase leronlimab trial missed its primary and all major secondary endpoints, but the company borrowed from COVID-19 gimmicks, and its stock price continued to rise in the process .
-
Drug Administration issued a document to regulate online prescription drugs
Time of Update: 2021-12-08
The "Regulations" stated that when pharmaceutical retail companies sell prescription drugs online, they should ensure that the source of electronic prescriptions is authentic and reliable, conduct prescription deployment reviews in strict accordance with relevant requirements, and mark the use of electronic prescriptions that have been used .
-
AstraZeneca's IL-5 inhibitor Fasenra was granted fast track approval by the FDA
Time of Update: 2021-12-08
S. Food and Drug Administration as a fast-track approval designation for the treatment of eosinophilic gastroenteritis with or without it.
-
GlaxoSmithKline first-in-class antibiotics apply for clinical application in China
Time of Update: 2021-12-08
Article source: Medical Rubik's Cube InfoAuthor: Shi BeiOn November 11, the CDE official website showed that the clinical application of GSK's new antibiotic Gepotidacin tablets was accepted by the State Food and Drug Administration .
-
In order to accelerate innovation, pharmaceutical companies set off a "wave of cooperation"
Time of Update: 2021-12-08
For example, on November 10, Tianjing Bio announced that it had reached a product development, production and commercialization cooperation with Jichuan Pharmaceutical on the highly differentiated long-acting recombinant human growth hormone eftansomatropin alfa (eftansomatropin alfa, TJ101) .
-
The pharmacy's strictest inspection is here
Time of Update: 2021-12-08
The "Detailed Rules" clearly requires that the provincial drug regulatory bureau (hereinafter referred to as the provincial bureau) conduct related inspections for drug retail chain headquarters, third-party drug online trading platforms, drug wholesale companies, drug manufacturers and other units, and the provincial bureaus shall check the drug safety risks Take effective risk control measures to organize the investigation and punishment of the above-mentioned corporate violations of laws and regulations and major cross-regional violations of laws and regulations .
